Reflecting on a Remarkable 2024; See You in 2025!

It’s our favorite time of the year, which means our team is out of the office from December 24 through January 3, taking a well-deserved break with family and friends.


As 2024 draws to a close, I want to express my heartfelt gratitude to the Georgia Bio community for an extraordinary year. Together, we have continued to advance our shared mission of fostering innovation, collaboration, and growth within the life sciences sector. Last week, we also hosted the final meeting of the year with the Georgia Bio board, sharing our vision for the association’s future growth. A special thank you to our board chair, Steve Damon, for your leadership and vision during a transitional year where we re-emerged as a 501c6 non-profit allowing us to further our policy and advocacy work which our previous designation did not allow. This significant change prepares us to have a stronger voice as we get ready to enter the 2025 legislative session. 


Our rapidly growing membership is a testament to the energy, diversity, and strength of our community. Your contributions—whether through new ideas, partnerships, or engagement—continue to propel our industry forward and solidify Georgia as a leader in life sciences innovation. Looking ahead to 2025, we are excited to build on the momentum in 2025. Our focus will be to create high-value programs, strengthen collaborations, advocate for the industry and our members at the state and federal level, and open doors to new opportunities that drive progress and improve lives through science. Together, we will tackle challenges, celebrate achievements, and continue shaping the future of the life sciences.


On behalf of Georgia Bio, I wish you a joyous holiday season filled with peace, happiness, and inspiration. I look forward to welcoming members at the Georgia Bio State Affiliate Reception at JPMorgan in early January and invite you to Save the Date for a Georgia Bio Member Appreciation reception the evening of Feb. 11th. 


Thank you for your unwavering support and commitment to our mission. Cheers to a bright and impactful 2025!

Maria

------------------------------------------

While we're out, we invite you to share in one to two words, what you are most optimistic about for 2025. Maybe your team is growing, you are starting a clinical trial or expanding your portfolio, excited about a transformative trend in the industry, or maybe you’re a optimistic about changes to the capital markets or regulatory landscape.

Click Here or Scan QR Code.

Georgia General Assembly Establishes Life Sciences Caucus to Advance Innovation and Industry Growth

March 17, 2026
Georgia Life Sciences leads effort to establish bipartisan caucus focused on advancing the state’s growing life sciences economy

Education And Opportunity Mark Strength Of Atlanta Biotech Industry

March 13, 2026
A skilled workforce is the engine that will drive growth across America’s biotechnology industry, and Atlanta has built multi-faceted training programs that are developing and sustaining the talent pipeline for everything from advanced laboratory research to industrial biomanufacturing.

Growing Georgia Biomanufacturing Industry Transforming American Industrial Strength

March 12, 2026
On March 12, 2026, Augusta, Georgia served as the setting for an important conversation about the future of American biotechnology and manufacturing. Manus welcomed members of the U.S. National Security Commission on Emerging Biotechnology (NSCEB) to its Augusta BioFacility to highlight how advanced biomanufacturing is strengthening U.S. supply chain resilience and supporting the growing bioeconomy. During the visit, Manus unveiled a significant expansion of its 44-acre Augusta BioFacility, increasing domestic capacity to produce critical biobased ingredients. The expansion further positions Georgia as a key hub for advanced biomanufacturing and demonstrates the growing role of biotechnology in strengthening national economic and supply chain security. Commission members met with leaders from industry, government, and academia to discuss strategies for scaling manufacturing infrastructure, strengthening resilient supply chains, and preparing the workforce needed to support the next generation of the U.S. bioeconomy. The visit also included conversations with Manus employees about the practical realities of building and operating advanced biomanufacturing facilities in the United States. The Augusta site has become one of the largest advanced biomanufacturing facilities in the country, producing a growing portfolio of bioalternatives at industrial scale. Among these products is high-purity Reb M, recently launched as Yume™ M Stevia Sweetener , supported by an all-Americas supply chain. “As we scale the Manus bioalternatives platform, Augusta has become a powerful example of what the modern U.S. bioeconomy looks like in practice,” said Manus Founder and CEO Ajikumar Parayil. The visit underscores Georgia’s expanding leadership in life sciences manufacturing and highlights how regional ecosystems can help advance U.S. leadership in biotechnology and biomanufacturing. Learn more about the expansion and visit: Manus welcomes U.S. National Security Commission on Emerging Biotechnology to unveil major Augusta BioFacility expansion Growing Georgia Biomanufacturing Industry Transforming American Industrial Strength
MORE POSTS